Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(S)-4-((S)-1-((3S,6R,11R,14S,17S,20S,26S,31aS)-3-((1H-imidazol-5-yl)methyl)-17-((1H-indol-3-yl)methyl)-14-(2-amino-2-oxoethyl)-6-((5S,8S,11S)-16-amino-5-carbamoyl-16-imino-8-isopropyl-7,10-dioxo-2-thia-6,9,15-triazahexadecan-11-ylcarbamoyl)-20-isopropyl-26-methyl-1,4,12,15,18,21,24,27-octaoxooctacosahydro-1H-pyrrolo[2,1-j][1,2,5,8,11,14,17,20,23,26]dithiaoctaazacyclononacosin-11-ylamino)-3-methyl-1-oxobutan-2-ylamino)-3-((S)-2-acetamido-3-phenylpropanamido)-4-oxobutanoic acid
ID: ALA1689451
Chembl Id: CHEMBL1689451
Max Phase: Preclinical
Molecular Formula: C78H113N23O19S3
Molecular Weight: 1773.11
Molecule Type: Protein
Associated Items: